Correspondence 0001193125-24-021895 from Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc.
Date: Feb. 1, 2024 · CIK: 0001420565 · Accession: 0001193125-24-021895
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276746
Letter
Acceleration Request
February 1, 2024
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Lauren Hamill
Re: Aileron Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-276746
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-276746), so that it may become effective at 4:30 p.m., Eastern time, on February 5, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
By:
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request February 1, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Lauren Hamill Re: Aileron Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-276746 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aileron Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-276746), so that it may become effective at 4:30 p.m., Eastern time, on February 5, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, By: /s/ Manuel C. Alves Aivado, M.D., Ph.D. Manuel C. Alves-Aivado, M.D., Ph.D. Chief Executive Officer cc: Stuart Falber, Wilmer Cutler Pickering Hale and Dorr LLP Craig Hilts, Wilmer Cutler Pickering Hale and Dorr LLP